... 24 patients with mild to moderate Alzheimer's disease who were randomly assigned to receive GAMMAGARD Liquid, GAMMAGARD S/D or placebo for six months. ...
In this study, 24 patients with mild to moderate Alzheimer’s disease were randomly assigned to receive GAMMAGARD Liquid, GAMMAGARD S/D or placebo (eight ...
In this study, 24 patients with mild to moderate Alzheimer’s disease were randomly assigned to receive GAMMAGARD Liquid, GAMMAGARD S/D or placebo (eight ...
Immune Globulin Intravenous (HUMAN | charts | news | PowerRating)(IGIV | charts | news | PowerRating) products like GAMMAGARD LIQUID and GAMMAGARD S/D are ...